CDC Opioid-Guideline Criticism Persists After Public-Comment Deadline
The reportedly September 19, 2026 Reagan-Udall public-comment deadline has passed, but debate continues over CDC/FDA evidence framing, MME interpretation, and individualized chronic-pain care. Patient accounts of tapering reinforce concerns about withdrawal, worsening pain, and loss of function; broader advocacy claims still require corroboration.
Sources (3)
Updated Sep 21, 2026